ACTG A5163: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ON

Medicine & Life Sciences

1. Alendronate 100%
2. Bone Density 83%
3. Acquired Immunodeficiency Syndrome 63%
4. Vitamin D 56%
5. Bone Marrow 55%
6. Placebos 42%
7. Calcium 41%
8. Clinical Trials 39%
9. Photon Absorptiometry 32%
10. HIV 31%
11. Nurses 22%
12. Organized Financing 18%
13. National Institutes of Health (U.S.) 15%
14. Osteoporosis 13%
15. Multicenter Studies 13%
16. Communicable Diseases 13%
17. Research Personnel 10%
18. Diet 10%
19. Bone and Bones 9%
20. Therapeutics 7%
21. Pharmaceutical Preparations 6%
22. Population 5%